The world's biggest trial of Grail Inc's (GRAL.O) flagship Galleri blood test will begin from Monday in Britain's state-run National Health Service which may help to detect more than 50 types of cancer before symptoms appear. Because earlier diagnosis of cancers leads to dramatically increased survival rates, The